Olivier Boisteau

Biography

In course of his studies at the Sorbonne, Olivier integrated Inserm to carry out research as part of his thesis on an anti-colon cancer vaccine. Following this period, he returned to the team of Dr.Yannick Jacques as a Post-Doctoral scientist in a programme to develop agonists-antagonists recombinant proteins of cytokine receptors. This development is part of a European wide programme. Having a strong vision for advancement of the bio therapeutic industry, Olivier, along with Frédéric Henry and Marc Meichenin launched into a previously uncharted adventure,based on knowledge of the eradication of mycoplasma in cell culture. Consequently, the birth of Clean Cells followed on 31 July 2000. Olivier, is also a member of the board of administration of Altanpole Biotherapies, a Biotech committee of LEEM.

Research Interest

Pharmaceutical Sciences